drugset / Trial / NCT02238756
Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this clinical trial is to investigate the safety and tolerability of IM administered CV8102 and an IM administered combination of CV8102 and rabies vaccine in humans.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-09
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CV8102 | Other / unclassified | — | Intramuscular |
| Comparator | Rabies vaccine | Vaccine | — | Intramuscular |